Imperial College London

DrAlexanderCarter

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Senior Lecturer
 
 
 
//

Contact

 

a.w.carter

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Naci:2015:10.1136/bmj.h5542,
author = {Naci, H and Carter, AW and Mossialos, E},
doi = {10.1136/bmj.h5542},
journal = {BMJ-BRITISH MEDICAL JOURNAL},
title = {Why the drug development pipeline is not delivering better medicines},
url = {http://dx.doi.org/10.1136/bmj.h5542},
volume = {351},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Despite the large number of new medicines entering the market every year, few offer importantclinical advantages for patients. Huseyin Naci, Alexander Carter, and Elias Mossialos explainthe reasons for this innovation deficit and offer some solutions
AU - Naci,H
AU - Carter,AW
AU - Mossialos,E
DO - 10.1136/bmj.h5542
PY - 2015///
SN - 1756-1833
TI - Why the drug development pipeline is not delivering better medicines
T2 - BMJ-BRITISH MEDICAL JOURNAL
UR - http://dx.doi.org/10.1136/bmj.h5542
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364146900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/48127
VL - 351
ER -